These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17804235)

  • 1. Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong.
    Yau TK; Soong IS; Chan K; Chang A; Sze H; Yeung MW; Tung R; Lau S; Lee A
    Breast; 2008 Feb; 17(1):58-63. PubMed ID: 17804235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.
    Sun JM; Han W; Im SA; Kim TY; Park IA; Noh DY; Heo DS; Bang YJ; Choe KJ; Kim NK
    Cancer; 2004 Dec; 101(11):2516-22. PubMed ID: 15517588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
    Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer.
    Jung SY; Han W; Lee JW; Ko E; Kim E; Yu JH; Moon HG; Park IA; Oh DY; Im SA; Kim TY; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2009 May; 16(5):1112-21. PubMed ID: 19219507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy.
    Garassino I; Gullo G; Orefice S; Tondulli L; Masci G; Salvini P; Eboli M; Di Tommaso L; Giordano L; Alloisio M; Roncalli M; Santoro A
    Breast; 2009 Aug; 18(4):263-6. PubMed ID: 19682903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome differences between patients with node-negative breast cancer classified according to the st. Gallen risk categories.
    Blancas I; Gómez FJ; Bermejo B; Hennessy BT; Chirivella I; Magro A; Caballero A; Ferrer J; Valero V; Lluch A
    Clin Breast Cancer; 2009 Nov; 9(4):231-6. PubMed ID: 19933078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the St Gallen classification for patients with node-negative breast cancer may lead to overuse of adjuvant chemotherapy.
    Boyages J; Chua B; Taylor R; Bilous M; Salisbury E; Wilcken N; Ung O
    Br J Surg; 2002 Jun; 89(6):789-96. PubMed ID: 12027994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
    Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk index for early node-negative breast cancer.
    Boyages J; Taylor R; Chua B; Ung O; Bilous M; Salisbury E; Wilcken N
    Br J Surg; 2006 May; 93(5):564-71. PubMed ID: 16607692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Her-2/neu gene overexpression in breast carcinoma and its association with clinicopathological characteristics of the disease.
    Ahmad A; Bano U; Gondal M; Khan A
    J Coll Physicians Surg Pak; 2009 May; 19(5):297-9. PubMed ID: 19409162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.